52 related articles for article (PubMed ID: 11296046)
1. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia.
Bhattacharyya N; Tarsy D
Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):389-92. PubMed ID: 11296046
[TBL] [Abstract][Full Text] [Related]
2. Oromandibular dystonia: from onset to spread a multicenter italian study.
Trinchillo A; Esposito M; Terranova C; Rizzo V; Fabbrini G; Ferrazzano G; Belvisi D; Erro R; Barone P; Bono F; Di Biasio F; Bentivoglio AR; Lettieri C; Altavista MC; Scaglione CLM; Albanese A; Mascia MM; Muroni A; Pisani A; Berardelli A; Defazio G
Neurol Sci; 2024 Mar; ():. PubMed ID: 38536550
[TBL] [Abstract][Full Text] [Related]
3. Oromandibular Dystonia Treatment With Aripiprazole in an Adolescent Patient 2-Year Follow-Up: A Case Report.
Gümüş YY; Say GN
Psychiatry Clin Psychopharmacol; 2021 Sep; 31(3):358-360. PubMed ID: 38765940
[TBL] [Abstract][Full Text] [Related]
4. Effects of Botulinum Toxin Therapy on Health-Related Quality of Life Evaluated by the Oromandibular Dystonia Rating Scale.
Yoshida K
Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287925
[TBL] [Abstract][Full Text] [Related]
5. Quality of Life Postchronic Tonsillitis Treatments: An Original Research.
Ahmed A; Nivedita ; Gabhale SD; Tiwari HD; Varma PK; Kudagi VS; Ahmed S
J Pharm Bioallied Sci; 2022 Jul; 14(Suppl 1):S307-S309. PubMed ID: 36110644
[TBL] [Abstract][Full Text] [Related]
6. Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.
Yoshida K
Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448891
[TBL] [Abstract][Full Text] [Related]
7. Oromandibular Dystonia: A Clinical Examination of 2,020 Cases.
Scorr LM; Factor SA; Parra SP; Kaye R; Paniello RC; Norris SA; Perlmutter JS; Bäumer T; Usnich T; Berman BD; Mailly M; Roze E; Vidailhet M; Jankovic J; LeDoux MS; Barbano R; Chang FCF; Fung VSC; Pirio Richardson S; Blitzer A; Jinnah HA
Front Neurol; 2021; 12():700714. PubMed ID: 34603182
[No Abstract] [Full Text] [Related]
8. Sleep and other Non-motor Symptoms in Patients with Idiopathic Oromandibular Dystonia and Meige Syndrome: A Questionnaire-based Study.
Ray S; Kutty B; Pal PK; Yadav R
Ann Indian Acad Neurol; 2021; 24(3):351-355. PubMed ID: 34446996
[TBL] [Abstract][Full Text] [Related]
9. Temporomandibular disorder-related characteristics and treatment outcomes in Oromandibular Dystonia patients in two different clinical settings: A cross-sectional study.
Sude A; Matsumoto J; Kaimal S; Petersen A; Nixdorf DR
J Oral Rehabil; 2021 May; 48(5):542-550. PubMed ID: 33682178
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in idiopathic dystonia: a systematic review.
Girach A; Vinagre Aragon A; Zis P
J Neurol; 2019 Dec; 266(12):2897-2906. PubMed ID: 30460447
[TBL] [Abstract][Full Text] [Related]
11. Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia.
Scorr LM; Silver MR; Hanfelt J; Sperin E; Freeman A; Jinnah HA; Factor SA
Neurotherapeutics; 2018 Apr; 15(2):452-458. PubMed ID: 29542022
[TBL] [Abstract][Full Text] [Related]
12. Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue.
Nastasi L; Mostile G; Nicoletti A; Zappia M; Reggio E; Catania S
J Neurol; 2016 Sep; 263(9):1702-8. PubMed ID: 27278063
[TBL] [Abstract][Full Text] [Related]
13. The Glasgow Benefit Inventory: a systematic review of the use and value of an otorhinolaryngological generic patient-recorded outcome measure.
Hendry J; Chin A; Swan IR; Akeroyd MA; Browning GG
Clin Otolaryngol; 2016 Jun; 41(3):259-75. PubMed ID: 26264703
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported benefit from oculoplastic surgery.
Smith HB; Jyothi SB; Mahroo OA; Shams PN; Sira M; Dey S; Adewoyin T; Cheung VT; Jones CA
Eye (Lond); 2012 Nov; 26(11):1418-23. PubMed ID: 22975655
[TBL] [Abstract][Full Text] [Related]
15. Patient benefit from treatment with botulinum neurotoxin A for functional indications in otorhinolaryngology.
Braun T; Gürkov R; Hempel JM; Berghaus A; Krause E
Eur Arch Otorhinolaryngol; 2010 Dec; 267(12):1963-7. PubMed ID: 20563590
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin in the management of dystonia.
Cardona-Garcia OD; Higgins DS; Molho ES
Curr Treat Options Neurol; 2007 May; 9(3):224-33. PubMed ID: 17445500
[TBL] [Abstract][Full Text] [Related]
17. Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations.
Papapetropoulos S; Singer C
Head Face Med; 2006 Dec; 2():47. PubMed ID: 17156419
[TBL] [Abstract][Full Text] [Related]
18. Laryngeal dystonia: case report and treatment with botulinum toxin.
Santos VJ; Mattioli FM; Mattioli WM; Daniel RJ; Cruz VP
Braz J Otorhinolaryngol; 2006; 72(3):425-7. PubMed ID: 17119783
[TBL] [Abstract][Full Text] [Related]
19. The psychosocial consequences of BOTOX injections for spasmodic dysphonia: a qualitative study of patients' experiences.
Baylor CR; Yorkston KM; Eadie TL; Maronian NC
J Voice; 2007 Mar; 21(2):231-47. PubMed ID: 16564675
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
